Leiterman

TL3 Regular · Split, HR

Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.

Joined 29 January 2025 · last posted 12h · groups: analytical-chemists

139 posts, newest first. Showing up to 150.

eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #46 · Clinical › Bloodwork · 27 Jul 2026 · 10 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
Spreadsheets: an appreciation — what changed since Replied, post #110 · Lounge › Off topic · 23 Jul 2026 · 7 likes Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #87 · Meta › Announcements · 21 Jul 2026 · 0 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
Which categories are strict and which are relaxed, honestly Replied, post #35 · Start Here › Welcome · 21 Jul 2026 · 0 likes This follows post #32 rather than contradicting it. Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #73 · Compounds › Retatrutide · 18 Jul 2026 · 31 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
Journal club: what we got wrong in an earlier session Replied, post #95 · Evidence › Journal club · 18 Jul 2026 · 19 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
Pooling trials with different estimands Replied, post #97 · Evidence › Meta-analyses · 14 Jul 2026 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #39 · Pharmacology › Formulation chemistry · 11 Jul 2026 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #73 · Analytics › Home & field testing · 11 Jul 2026 · 7 likes post #72 answers the question as asked. The question underneath it is different. Sample handling matters: if a sample is contaminated or degraded before testing, the…
Tracking a shortage from primary sources rather than rumour Replied, post #94 · Access › Shortages · 10 Jul 2026 · 0 likes Worth separating two things that post #90 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #56 · Compounds › Repair & healing peptides · 9 Jul 2026 · 25 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
Documenting a supplier's response to a discrepancy Replied, post #30 · Sourcing › Vendor reports · 4 Jul 2026 · 18 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
Carryover and the ghost peak from last week's standard — what changed since Replied, post #86 · Analytics › HPLC & UHPLC · 29 Jun 2026 · 16 likes Picking up post #83: that is the part I would want checked first. System suitability testing: injections run before and during the sample run to establish whether the…
Personal or family history of medullary thyroid carcinoma Replied, post #23 · Safety › Contraindications · 28 Jun 2026 · 0 likes Coming back to post #21, because the follow-up matters more than the original answer. Severe renal impairment (eGFR
When a dose reduction is the correct response to a side effect Replied, post #33 · Practice › Dosing & titration · 26 Jun 2026 · 4 likes I read post #31 twice before replying, because I had assumed the opposite. Reaching a dose and staying there for a year: the question of whether a stable dose remains…
Second pass at: When your prescriber and the evidence disagree Replied, post #40 · Clinical › Prescriber conversations · 24 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #38 · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 4 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
Official shortage notices and what they authorise Replied, post #109 · Access › Shortages · 16 Jun 2026 · 1 like Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #17 · Pharmacology › Receptor biology · 13 Jun 2026 · 7 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #38 · Evidence › Journal club · 10 Jun 2026 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
Does dual agonism explain the effect size, or is it dose? Replied, post #13 · Compounds › Tirzepatide · 2 Jun 2026 · 4 likes This follows post #10 rather than contradicting it. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to…
Second pass at: Absence of evidence and evidence of absence Replied, post #10 · Research Methods › Statistics · 27 May 2026 · 9 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Comparing prices across jurisdictions without misleading yourself Started this topic · Access › Pricing · 23 May 2026 · 2 likes Comparing prices across jurisdictions without misleading yourself — setting out what I have, and where I think it stops being reliable. A coverage question with the…
What steady state means for the decision to escalate Started this topic · Practice › Dosing & titration · 10 May 2026 · 1 like What steady state means for the decision to escalate — that is the question, and I have not found it answered plainly anywhere I have looked. Reporting something rather…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #20 · Practice › Storage & stability · 8 May 2026 · 0 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #21 · Compounds › Tirzepatide · 4 May 2026 · 2 likes On post #17 — agreed on the reasoning, with one qualification. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means…
Coming back to: Measurement error in a self-reported exposure Replied, post #27 · Evidence › Study critique · 29 Apr 2026 · 11 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #32 · Start Here › Welcome · 27 Apr 2026 · 3 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #11 · Practice › Administration · 27 Apr 2026 · 0 likes Picking up post #8: that is the part I would want checked first. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in…
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #2 · Evidence › Meta-analyses · 27 Apr 2026 · 31 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
[2026 update] Composite endpoints and the component doing the work Replied, post #85 · Evidence › Trials · 25 Apr 2026 · 26 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #29 · Devices › Syringes & needles · 14 Apr 2026 · 8 likes post #28 is right about the mechanism and I think understates the practical bit. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead…
Follow-up: State-level differences that actually matter Replied, post #93 · Regional › North America · 9 Apr 2026 · 0 likes Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream…
Preprint servers and what screening they do Replied, post #103 · Evidence › Preprints · 26 Mar 2026 · 5 likes post #102 answers the question as asked. The question underneath it is different. Discussing preprints in this community: bring them in for early discussion, label them…
Follow-up: Levothyroxine timing: a real interaction with a simple fix Replied, post #6 · Practice › Interactions · 23 Mar 2026 · 15 likes Coming back to post #4, because the follow-up matters more than the original answer. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A,…
Documenting a payment dispute without naming and shaming Replied, post #5 · Sourcing › Payments · 21 Mar 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Preprint servers and what screening they do Replied, post #92 · Evidence › Preprints · 17 Mar 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Research-use-only status: what it means legally and practically Replied, post #13 · Compounds › Other compounds · 11 Mar 2026 · 33 likes Picking up post #10: that is the part I would want checked first. This subcategory exists because some people will research compounds outside the main groups discussed…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #16 · Lounge › Introductions · 8 Mar 2026 · 6 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
Contributing data without breaching anyone's privacy Replied, post #10 · Data & Tools › Datasets · 2 Mar 2026 · 0 likes Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current.
Waist circumference technique and its repeatability Replied, post #55 · Outcomes › Progress reports · 23 Feb 2026 · 0 likes This follows post #52 rather than contradicting it. Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #137 · Analytics › COA interpretation · 21 Feb 2026 · 0 likes I read post #135 twice before replying, because I had assumed the opposite. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #44 · Outcomes › Progress reports · 12 Feb 2026 · 0 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #4 · Practice › Administration · 9 Feb 2026 · 7 likes I read post #2 twice before replying, because I had assumed the opposite. Cold solution and stinging: warming the vial in your hands for a minute before injection…
Reading an interaction checker output critically Replied, post #111 · Practice › Interactions · 5 Feb 2026 · 1 like post #110 answers the question as asked. The question underneath it is different. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #21 · Pharmacology › Pharmacokinetics · 21 Jan 2026 · 9 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
Amylin receptor signalling and satiety — what changed since Replied, post #18 · Pharmacology › Receptor biology · 19 Jan 2026 · 19 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #9 · Evidence › Trials · 16 Jan 2026 · 32 likes Coming back to post #7, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #77 · Clinical › Special populations · 16 Jan 2026 · 28 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #62 · Access › Pricing · 15 Jan 2026 · 0 likes post #61 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #53 · Compounds › Semaglutide · 8 Jan 2026 · 0 likes post #52 is right about the mechanism and I think understates the practical bit. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that…
[2026 update] Availability by country, dated, with primary sources Replied, post #9 · Access › International · 6 Jan 2026 · 4 likes This follows post #6 rather than contradicting it. Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide…
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #38 · Analytics › Method validation · 5 Jan 2026 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Reconstitution volumes that produce round numbers, tabulated Replied, post #19 · Practice › Reconstitution · 3 Jan 2026 · 1 like Picking up post #16: that is the part I would want checked first. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per…
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 23 Dec 2025 · 14 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
Meeting a protein target on a suppressed appetite Replied, post #44 · Nutrition & Training › Protein & intake · 22 Dec 2025 · 0 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
Preprint servers and what screening they do Replied, post #5 · Evidence › Preprints · 21 Dec 2025 · 32 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #20 · Practice › Side effects · 6 Dec 2025 · 0 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
Tracking a preprint to publication: a worked example Replied, post #56 · Evidence › Preprints · 5 Dec 2025 · 11 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #6 · Sourcing › Red flags · 4 Dec 2025 · 0 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #14 · Compounds › Tirzepatide · 1 Dec 2025 · 5 likes This follows post #11 rather than contradicting it. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving…
Reconstitution volumes that produce round numbers, tabulated Started this topic · Practice › Reconstitution · 24 Nov 2025 · 13 likes Reconstitution volumes that produce round numbers, tabulated — setting out what I have, and where I think it stops being reliable. Practical question with the units…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #57 · Compounds › Oral incretins · 23 Nov 2025 · 0 likes This follows post #54 rather than contradicting it. Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no…
Pen dose counters: what a click does and does not guarantee Replied, post #110 · Devices › Pens & autoinjectors · 19 Nov 2025 · 0 likes This follows post #107 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Thyroid function tests during substantial weight change Replied, post #137 · Clinical › Bloodwork · 16 Nov 2025 · 0 likes This follows post #134 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Second pass at: MALDI versus ESI for a quick identity check Replied, post #2 · Analytics › Mass spectrometry · 14 Nov 2025 · 0 likes the opening post answers the question as asked. The question underneath it is different. Calibration matters: a high-resolution instrument out of calibration can report…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #45 · Compounds › Semaglutide · 11 Nov 2025 · 3 likes On post #41 — agreed on the reasoning, with one qualification. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4…
Second pass at: The mass-error checker and its intended scope Replied, post #60 · Data & Tools › Calculators · 10 Nov 2025 · 0 likes Picking up post #57: that is the part I would want checked first. Mass error checking: enter your observed mass and theoretical mass and check whether the difference in…
Meeting a protein target on a suppressed appetite Replied, post #31 · Nutrition & Training › Protein & intake · 28 Oct 2025 · 20 likes This follows post #28 rather than contradicting it. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as…
What pooling buys you and what it destroys Replied, post #52 · Evidence › Meta-analyses · 27 Oct 2025 · 3 likes Coming back to post #50, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
Oral semaglutide bioavailability and its variability between people Replied, post #11 · Compounds › Oral incretins · 25 Oct 2025 · 29 likes Coming back to post #9, because the follow-up matters more than the original answer. Fasting instructions are not optional advice. Taking the tablet with food or with…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #72 · Practice › Reconstitution · 24 Oct 2025 · 11 likes I read post #70 twice before replying, because I had assumed the opposite. Choosing a concentration on purpose rather than by accident: starting with "I want to draw…
What a purity-only report leaves out Replied, post #45 · Sourcing › Independent verification · 13 Oct 2025 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #17 · Analytics › HPLC & UHPLC · 1 Oct 2025 · 0 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
What a purity-only report leaves out Replied, post #12 · Sourcing › Independent verification · 12 Sep 2025 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #129 · Wellbeing › Mental health · 9 Sep 2025 · 29 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #29 · Data & Tools › Datasets · 7 Sep 2025 · 4 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #23 · Analytics › Method validation · 3 Sep 2025 · 13 likes This follows post #20 rather than contradicting it. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #61 · Evidence › Journal club · 30 Aug 2025 · 15 likes This follows post #58 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #5 · marked as the solution · Compounds › Tirzepatide · 23 Aug 2025 · 11 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #77 · Sourcing › Regulatory · 12 Aug 2025 · 1 like Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
High-resolution MS on aggregates and what it can see Replied, post #40 · Analytics › Mass spectrometry · 9 Aug 2025 · 3 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
State-level differences that actually matter Replied, post #8 · Regional › North America · 4 Aug 2025 · 0 likes On post #4 — agreed on the reasoning, with one qualification. Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer…
A ten-fold dose error caught before injection — one year on Replied, post #3 · Devices › Syringes & needles · 31 Jul 2025 · 19 likes post #2 is right about the mechanism and I think understates the practical bit. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #77 · Compounds › Repair & healing peptides · 22 Jul 2025 · 13 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #22 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2025 · 0 likes On post #18 — agreed on the reasoning, with one qualification. The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #12 · Analytics › Method validation · 11 Jul 2025 · 0 likes post #11 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
Antibiotics and a course of something with delayed emptying Replied, post #70 · Practice › Interactions · 20 Jun 2025 · 0 likes This follows post #67 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #31 · Evidence › Journal club · 8 Jun 2025 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Pre-registering a personal experiment, seriously Replied, post #100 · Research Methods › N-of-1 designs · 3 Jun 2025 · 25 likes I read post #98 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
History of disordered eating and why it changes the conversation Started this topic · Clinical › Special populations · 2 Jun 2025 · 0 likes History of disordered eating and why it changes the conversation Writing it up because I had to work it out twice and would rather nobody else did. Asking about a…
A report I filed that turned out to be wrong, and the correction Replied, post #74 · Sourcing › Vendor reports · 28 May 2025 · 8 likes Worth separating two things that post #70 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #158 · Sourcing › Regulatory · 22 May 2025 · 8 likes On post #154 — agreed on the reasoning, with one qualification. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is…
A supplier that answers analytical questions with restated claims Replied, post #79 · Sourcing › Red flags · 19 May 2025 · 0 likes Coming back to post #77, because the follow-up matters more than the original answer. Inability to trace lots: if you ask "where was this synthesised, by whom, under…
A claim built entirely on a subgroup analysis Replied, post #42 · Evidence › Study critique · 18 May 2025 · 9 likes Picking up post #39: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
DXA precision and the least significant change for lean mass — the long version Replied, post #46 · Outcomes › Body composition · 15 May 2025 · 0 likes Coming back to post #44, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #82 · Sourcing › Independent verification · 12 May 2025 · 15 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
Follow-up: Documentation that appears only after payment Replied, post #61 · Sourcing › Red flags · 9 May 2025 · 7 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
Shakes versus food: a pragmatic assessment — the long version Replied, post #17 · Nutrition & Training › Protein & intake · 6 May 2025 · 26 likes Coming back to post #15, because the follow-up matters more than the original answer. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #51 · Compounds › Secretagogues & GH axis · 28 Apr 2025 · 0 likes I read post #49 twice before replying, because I had assumed the opposite. What a well-designed human trial of a secretagogue would look like: randomised,…
Dizziness on standing: the ordinary explanation first Replied, post #16 · Nutrition & Training › Hydration & electrolytes · 26 Apr 2025 · 0 likes Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain sodium balance. Very low sodium intake on these compounds raises…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #7 · Sourcing › Independent verification · 23 Apr 2025 · 7 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Validating a calculator against hand arithmetic — what changed since Replied, post #25 · Data & Tools › Calculators · 20 Apr 2025 · 17 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
Reading order for a first week here, and what to skip until later Replied, post #89 · Start Here › Welcome · 18 Apr 2025 · 12 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #40 · Compounds › Other compounds · 8 Apr 2025 · 17 likes Coming back to post #38, because the follow-up matters more than the original answer. When "no data" is the complete and final answer: if there is no published human…
Sequence verification for an obscure compound: how it is done Replied, post #6 · Compounds › Other compounds · 4 Apr 2025 · 0 likes post #5 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
Why cagrilintide alone is discussed so much less than in combination Replied, post #70 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
When "no data" is the complete and final answer Replied, post #124 · Compounds › Other compounds · 21 Mar 2025 · 19 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
Validating a method you did not develop — does this still hold? Replied, post #141 · Analytics › Method validation · 20 Mar 2025 · 0 likes post #140 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #38 · Sourcing › Vendor reports · 16 Mar 2025 · 5 likes I read post #36 twice before replying, because I had assumed the opposite. Multiple services on one lot: agreement across two independent laboratories is stronger than…
Coming back to: What published stability data actually covers, and what it does not Replied, post #6 · Practice › Storage & stability · 16 Mar 2025 · 13 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
Charge states for a 4 kDa peptide, worked through Replied, post #80 · Analytics › Mass spectrometry · 11 Mar 2025 · 15 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #51 · Practice › Reconstitution · 11 Mar 2025 · 6 likes Worth separating two things that post #47 runs together. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
Washout: how long is long enough, and for what purpose Replied, post #9 · Pharmacology › Pharmacokinetics · 10 Mar 2025 · 1 like Coming back to post #7, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
Validating a method you did not develop — does this still hold? Replied, post #56 · Analytics › Method validation · 28 Feb 2025 · 32 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
Distinguishing a deletion sequence by mass alone Replied, post #127 · Analytics › Mass spectrometry · 24 Feb 2025 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Follow-up: What other technical communities get right that we do not Replied, post #21 · Lounge › Off topic · 19 Feb 2025 · 3 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
Coming back to: Adsorption to container surfaces and to plastics Replied, post #3 · Pharmacology › Formulation chemistry · 14 Feb 2025 · 5 likes On the opening post — agreed on the reasoning, with one qualification. Excipients and their purposes: mannitol, sucrose, or other sugars in lyophilised formulations…
Follow-up: Individual participant data versus aggregate data Replied, post #109 · Evidence › Meta-analyses · 12 Jan 2025 · 26 likes Picking up post #106: that is the part I would want checked first. Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same…
The topic list is dense — is that deliberate? Replied, post #74 · Meta › Site feedback · 29 Dec 2024 · 2 likes This follows post #71 rather than contradicting it. Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you,…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #42 · Compounds › Cagrilintide & amylin analogues · 29 Dec 2024 · 10 likes post #41 answers the question as asked. The question underneath it is different. Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #165 · Analytics › COA interpretation · 26 Dec 2024 · 0 likes This follows post #162 rather than contradicting it. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #39 · Compounds › Semaglutide · 25 Dec 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Identical chromatograms across two different lots Replied, post #63 · Sourcing › Red flags · 16 Dec 2024 · 6 likes I read post #61 twice before replying, because I had assumed the opposite. Anonymity: a supplier that will not disclose legal name, address, or responsible person is…
Washout with a one-week half-life: the arithmetic Replied, post #83 · Research Methods › N-of-1 designs · 7 Dec 2024 · 16 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
Time to steady state after a dose increase Replied, post #43 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 0 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
Identical chromatograms across two different lots Replied, post #34 · Sourcing › Red flags · 8 Oct 2024 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #101 · Sourcing › Independent verification · 1 Oct 2024 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
Blind submission and why it changes minds Replied, post #75 · Sourcing › Independent verification · 30 Sep 2024 · 19 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #38 · Evidence › Journal club · 8 Sep 2024 · 15 likes post #37 answers the question as asked. The question underneath it is different. Session format: read the paper before posting. The discussion is much better when…
Promotion criteria, and the one that stops most nominations Replied, post #53 · Documentation › Doc review · 4 Sep 2024 · 13 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
High-resolution MS on aggregates and what it can see — one year on Replied, post #56 · Analytics › Mass spectrometry · 21 Aug 2024 · 18 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
Guidelines revision: what changed and why Replied, post #92 · Meta › Announcements · 27 Jul 2024 · 1 like Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
Guidelines revision: what changed and why Replied, post #77 · Meta › Announcements · 27 Jul 2024 · 0 likes post #76 is right about the mechanism and I think understates the practical bit. Questions welcomed: if an announcement is unclear, asking for clarification is welcome.…
Cold packs, phase-change material, and what survives ten days Replied, post #131 · Sourcing › Logistics · 22 Jul 2024 · 4 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
Second pass at: Sodium, potassium and magnesium when intake drops Started this topic · Nutrition & Training › Hydration & electrolytes · 13 Jul 2024 · 42 likes Second pass at: Sodium, potassium and magnesium when intake drops Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal report…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #98 · Practice › Dosing & titration · 9 Jul 2024 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
The mass-error checker and its intended scope Replied, post #65 · Data & Tools › Calculators · 21 Jun 2024 · 0 likes On post #61 — agreed on the reasoning, with one qualification. Precision and significant figures: the calculators do not round to match your input precision. If you…
Assessing a warm arrival: the decision process — one year on Replied, post #129 · Sourcing › Logistics · 2 Jun 2024 · 1 like Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…